{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreieekv2aitcfcukfosst2ibx5xkq2j4nlndilput43yobkfgx7yt2q",
    "uri": "at://did:plc:k7h5fn3kdhjpj37pc6yhno2o/app.bsky.feed.post/3menjulv37oi2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreie2ldt5npqcj33nfsafkrbznfz2m746zlsxucrg2klulizdo3dthi"
    },
    "mimeType": "image/jpeg",
    "size": 100885
  },
  "path": "/article/fda-wont-consider-a-new-mrna-vaccine-for-flu-despite-the-technologys-life/",
  "publishedAt": "2026-02-11T15:45:00.000Z",
  "site": "https://www.scientificamerican.com",
  "textContent": "The U.S.’s drug safety agency declined to review a next-gen flu vaccine that uses the same tech as the coronavirus shots",
  "title": "FDA won’t consider a new mRNA vaccine for flu despite the technology’s life-saving promise"
}